The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

ADHD as a Risk Factor for Substance Use Disorders | Increased Rates of ADHD in Substance Use Disorder Populations | Associations Between ADHD and Substance Use Disorders | Co-Occurring Disorders as Mediators of ADHD and Substance Use Disorder Comorbidity | Diagnosis of ADHD and Substance Use Disorders | Treatment Plan | Early Pharmacological Treatment for ADHD and Risk of Future Substance Use Disorders | Stimulant Misuse | Conclusion

Excerpt

An estimated 6%–8% of children (ages 2–18 years) in the United States are diagnosed with attention-deficit/hyperactivity disorder (ADHD), making this syndrome the most common neurobehavioral disorder presenting in childhood (Thomas et al. 2015). It is now widely recognized that ADHD persists into adulthood in one-half to two-thirds of cases (Wilens and Spencer 2010), with estimates from epidemiological data indicating that 4%–5% of adults struggle with ADHD (for a review, see Adler et al. 2015). ADHD is characterized by inattention and/or hyperactive and impulsive behaviors that are persistent across multiple settings to a degree that is inconsistent with developmental level and that give rise to social, familial, emotional, interpersonal, educational, or work performance difficulties. Compared with their non-ADHD peers, individuals with the diagnosis are also at increased risk for co-occurring learning disorders and psychiatric disorders, such as mood, anxiety, oppositional, conduct, and substance use disorders (for a review, see Adler et al. 2015).

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).